PALI Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Biotech Challenges SMR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Company Advances Technology FICO Q1 2026 Earnings EPS Surges 1165 Above Estimates Shares Rise GLUE Q1 2026 Earnings WiderThanExpected Loss as PreClinical Biotech Advances Pipeline Welltower Q1 2026 Earnings Stellar EPS Beat Bolsters Investor Confidence WRB Q1 2026 Earnings Strong EPS Beat Driven by Solid Underwriting and Investment Results